Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are anti-obesity and anti-diabetes medications that mimic the action of the endogenous incretin hormone GLP-1, which is released from the gut in response to food intake. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.